Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Ativan 4mg/ml Solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, colourless solution supplied in clear glass ampoules. |
Lorazepam 4 mg/ml.
Lorazepam (INN, BAN) is chemically defined as 7-chloro-5-(o-chlorphenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one.
Excipient(s) with known effect: Ativan Injection contains 20.9mg/ml benzyl alcohol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Lorazepam |
Lorazepam is a benzodiazepine with anxiolytic, sedative and hypnotic properties. |
| List of Excipients |
|---|
|
Polyethylene glycol 400 |
1ml solution in 2ml ampoules (Type I glass) with a one-point-cut opening, position marked by red spot in pack sizes of 10.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/1279
Date of latest renewal: 12 March 2009
| Drug | Countries | |
|---|---|---|
| ATIVAN | Ecuador, Estonia, Ireland, Malta, Mexico, New Zealand, Turkey, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
